PharmaShots | Incisive News in 3 Shots

Subscribe Now

immunotherapies

Gilead Signs an Option and License Agreement with Gritstone for HIV Vaccine

Gilead Signs an Option and License Agreement with Gritstone for HIV Vaccine

February 2, 2021

Eisai Signs a Research and Option Agreement with Numab to Discover and Develop Multi-Specific Antibody Immunotherapies for Cancer

Eisai Signs a Research and Option Agreement with Numab to Discover and Develop Multi-Specific Antibody Immunotherapies for Cancer

October 1, 2019

Thyas Signs an Exclusive License Agreement with iPS Academia Japan (iPS-AJ) to Develop Autologous Immunotherapies

Thyas Signs an Exclusive License Agreement with iPS Academia Japan (iPS-AJ) to Develop Autologous Immunotherapies

January 18, 2019

Eli Lilly Collaborates with Aduro Biotech for its cGAS-STING Pathway Inhibitor Program to Develop Immunotherapies

Eli Lilly Collaborates with Aduro Biotech for its cGAS-STING Pathway Inhibitor Program to Develop Immunotherapies

December 19, 2018

Leidos Collaborates with GeoVax for the Development of Immunotherapies for Cancer

Leidos Collaborates with GeoVax for the Development of Immunotherapies for Cancer

November 20, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us